Clinical Researches

The long-lasting effects of COVID-19, particularly post-COVID-19 syndrome, pose a significant challenge to both individuals and healthcare systems worldwide. Characterized by symptoms that linger...

Tracking the intersection of side-effect severity and treatment endurance illuminates the path to optimizing cancer care. In this transformative study, researchers mined data from...

Cancer patients face significant risks from surgery due to complications and potential functional decline. Factors like age, poor nutrition, smoking habits, and socioeconomic constraints...

In the heart of rural Uganda, where healthcare accessibility remains a challenge, a revolutionary mobile intervention, Call For Life - Interactive Voice Response (C4L-IVR),...

A new ray of hope emerges for patients battling recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) as the combination of cetuximab and...

In a landmark moment for ovarian cancer treatment, a phase III trial reveals promising developments for patients receiving rucaparib as a maintenance therapy. The...

The National Institute for Health and Care Excellence (NICE) recently updated its guidance to include Lorlatinib as an approved treatment for adults with advanced...

Incyte put a robust spotlight on its latest clinical advancements at the European Society of Medical Oncology (ESMO) Congress 2025, revealing encouraging Phase 1...

CSL Seqirus is making a significant impact at the European Scientific Working group on Influenza (ESWI) conference, a much-anticipated gathering for experts across the...

Wayrilz, a promising therapy from Sanofi targeting immune thrombocytopenia (ITP), has drawn a favorable recommendation from the Committee for Medicinal Products for Human Use...

Belumosudil, a promising therapy for chronic lung allograft dysfunction, recently gained approval for its pediatric investigation plan (PIP) from the European Medicines Agency (EMA)....

Accurate endpoints in clinical trials for genitourinary cancers such as prostate, bladder, and renal cancer have become a focal point, as researchers strive to...

As the world grapples with COVID-19 vaccine distribution, breakthrough infections present a conundrum, especially in areas dealing with the presence of new variants. Despite...

Acute myeloid leukemia (AML) is an aggressive cancer with limited curative options, particularly for those at high risk. Allogeneic hematopoietic stem cell transplantation (allo-HSCT)...

Efforts to improve treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC) have led researchers to explore the timing of immunotherapy...